Photo of Ritika Vankina, MD

Ritika Vankina, MD

Assistant Professor of Medicine
NPI Number:
1811314263
Academic Office Location:
Carole and Ray Neag Comprehensive Cancer Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030-8072
Phone: 800-579-7822
Website(s):

Carole and Ray Neag Comprehensive Cancer Center

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >
Education
DegreeInstitutionMajor
MBBSJ.J.M. Medical College/Rajiv Gandhi University of Health SciencesHealth Sciences
MPHUniversity of MassachusettsPublic Health

Post-Graduate Training
TrainingInstitutionSpecialty
FellowshipHarbor-UCLA Medical CenterHematology/Medical Oncology
ResidencyUMass Medical School-Baystate Medical CenterInternal Medicine

Awards
Name of Award/HonorAwarding Organization
Medicine Grand Rounds Geriatric Update Jeopardy - 1st PlaceUMass Medical School/Baystate Medical Center
Selected for Full Scholarship to Attend 2016 Southeast Center of Excellence in Geriatric Medicine Resident Award
Co-President of National Resident Section 2016American Geriatric Society
Recruitment Officer in Baystate Internal Medicine Residency Geriatric Track
Member of Research Track (2014-2016)

Journal Articles

  • Direct oral anticoagulant dose optimization in cancer-associated thrombosis: Current evidence and implications for extended therapy
    Ursula Matos, Moana Divina Da Silva Santiago, Patrick Froelich Meldola, Swarup Kumar, Ritika Vankina European Journal of Internal Medicine

Abstracts

  • A Retrospective Assessment of Genomic Perturbations in a Plasma Cell Disorder Cohort at our Institution.
    Kumar S, Kirk K, Hooper K, Vankina R International Myeloma Society, Athens, Greece 2023.
  • A Retrospective Review Assessing the Development of Myelodysplastic Syndromes in Patients with Plasma Cell Dyscrasias
    Kirk K, Hooper K, Vankina R, Kumar S Blood 142((Supplement 1)):6499
  • An evaluation of patient workflow in hematology clinics at a university hospital referred for the workup of monoclonal gammopathy of undetermined significance (MGUS).
    Kumar S., Kulkarni R., Ozcan G., Tipirneni A., Vankina R., Baker WJ. Journal of Clinical Oncology 2021 39:28_suppl, 207-207
  • Characterizing Genomic Variants Defining a Plasma Cell Disorder Patient Cohort Using a Broad Next Generation Multi-Gene DNA Sequencing Panel
    Kristin Ezell, Katharine Hooper, Kaylyn Kirk, Ritika Vankina, Swarup Kumar. ASH 2024
  • Diagnostic Patterns and Outcomes of Amyloidosis Screening in a Monoclonal Gammopathy Clinic: A Single Center Study
    Swarup Kumar, Kristin Ezell, Ritika Vankina Clinical Lymphoma, Myeloma and Leukemia 25:S244-S245
  • Efficacy and Safety of Caplacizumab in Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis.
    Ursula Medeiros Araujo de Matos, Pedro Luiz Lage Bodour Danielian, Ritika Vankina THSNA
  • Efficacy and safety of low-dose vs. standard-dose direct oral anticoagulants for secondary prevention of cancer associated thrombosis: A systematic review and meta-analysis
    Ursula Matos, Moana Divina Da Silva Santiago, Swarup Kumar, Gustavo Silva Sanchez ,Eduardo Dan, Patrick Froelich Meldola, Ritika Vankina
  • Efficacy and safety of low-dose vs. standard-dose direct oral anticoagulants for secondary prevention of venous thromboembolism: A systematic review and meta-analysis
    Ursula Matos, Moana Divina Da Silva Santiago, Ritika Vankina, Eduardo Dan, Gustavo Silva Sanchez, Oladipo Cole Blood 146(Supplement 1):1351-1351
  • Examining TP53-mutated plasma cell disorders across the disease spectrum using broad next generation sequencing
    Kristin Ezell, Shea-Lee Godin, Nour Abdallah, Olivia Steczko, Chidambaram Ramasamy, Ritika Vankina, Kapil Meleveedu, Swarup Kumar Blood 146(Supplement 1):4013-4013
  • Improving bone marrow biopsy core length and aspirate adequacy through implementation of a powered device: A single-institution quality improvement initiative
    Chidambaram Ramasamy, Andrea Moran, Dong Chen, Swarup Kumar, Ritika Vankina, Kapil Meleveedu Blood 146(Supplement 1):6176-6176
  • Infusional Chemotherapy Regimens for Multiple Myeloma: Characterization of Current-Day Use at a Single Center
    Olivia Steczko, Janani Arunachalam, Susmitha Talasila, Ritika Vankina, Swarup Kumar Clinical Lymphoma, Myeloma and Leukemia 25:S300
  • Optimizing Skeletal Health: A Retrospective Analysis of Bone-Modifying Agent Prescription Patterns and Incidence of Skeletal-Related Events in Multiple Myeloma
    Amy Huang, Ursula Matos, Anthony Zhang, Nicole Sequeira, Douglas Hackenyos, Ritika Vankina, Natalia Neparidze,Swarup Kumar Clinical Lymphoma, Myeloma and Leukemia 25:S117
  • Optimizing skeletal health: An analysis of bone-modifying agent prescription patterns and incidence of skeletal-related events in multiple myeloma
    Amy Huang, Nicole Sequeira, Anthony Zhang, Ursula Matos, Elan Gorshein, Talib Dosani, Ritika Vankina, Syed Ali, Natalia Neparidze, Swarup Kumar Blood 146(Supplement 1):4567-4567
  • Prevalence of Iron Deficiency in Reproductive-Age Females on Anticoagulation
    Brianna R. Bakow, MD, Rebecca L. Zon, MD, Shreya Agarwal, MD, Ming Y. Lim, MD, Anna L. Parks, MD, Madhvi Rajpurkar, MD, Rachel P. Rosovsky, MD, MPH, Bethany Samuelson Bannow, MD, MCR, Ritika Vankina, MD, MPH, Xin Yang, PhD, Lisa Baumann Kreuziger, MD Hemostasis and Thrombosis Research Society (HTRS) 2024
  • Prevalence of Iron Deficiency in Reproductive-Age Females on Anticoagulation
    Brianna R. Bakow, Rebecca L. Zon, Shreya Agarwal, Ming Y. Lim, Anna L. Parks, Madhvi Rajpurkar, Rachel P. Rosovsky, Bethany Samuelson Bannow, Ritika Vankina, Xin Yang, Lisa Baumann Kreuziger Research and Practice in Thrombosis and Haemostasis 9:103108
  • The Role of CHIP Mutations in Plasma Cell Dyscrasias: Implications for Clonal Evolution and Risk Stratification
    Kristin Ezell, Shea-Lee Godin, Vladimir Osadchyi,Olivia Steczko, Ritika Vankina, Kapil Meleveedu, Swarup Kumar Clinical Lymphoma, Myeloma and Leukemia 25:S145-S146
  • Thrombotic Significance in Plasma Cell Disorders: Do associated clonal hematopoiesis of indeterminate potential (CHIP) mutations increase the risk?
    Vankina R, Kirk K, Reddy A, Hooper K, and Kumar S. International Myeloma Society, Athens, Greece 2023. (S2, S1-S356, 2023):102
  • Utilization of the Khorana score (KS) by hematology/oncology clinicians in the ambulatory setting. ASCO Quality Care Symposium, Chicago 2022.
    Emmich M, Kidwai N, Holle L, and Vankina R. Ascopub

Case Reports

  • A case of gamma heavy chain disease: a rare B-cell disorder with successful therapeutic response.
    Clark J, Kumar S, Vankina R Northern New England Clinical Oncology Society
  • Acquired Hemophilia A and STEMI: A Management Dilemma.
    Jevin, Y., Lima G., Vankina R., Kumar S., and Meng J. Cureus. 2023 May 4;15(5):e38549. doi: 10.7759/cureus.38549. PMID: 37288205
  • An Uncommon Encounter with Tumor Lysis Syndrome in Colorectal Cancer.
    Wan Ying Tan, MD, Ursula Medeiros Araujo de Matos, MD, Qian Wu, MD, Faripour Forouhar, MD, Ritika Vankina, MD, Pragna Kapadia, MD, Victoria Forbes, MD, MS New England Clinical Oncology Society Annual Meeting, Bretton Woods, New Hampshire, October 2024. Resident/Fellow Travel Grant Recipient.
  • Autoimmune hemolytic anemia as a harbinger of lymphoma
    Emmich M., Forbes V., Vankina R Northern New England Clinical Oncology Society
  • Normal karyotype FLT3 mutated Acute Myeloid Leukemia with Chronic Myeloid Leukemia; a rare diagnosis
    Kolandra L., Emmich M., Kapadia P., Vankina R 2021 International Congress on Myeloproliferative Neoplasms
  • Successful hemin transfusion in a pregnant patient with acute intermittent porphyria but without a diagnostic gene mutation.
    Amy Huang, MD, Victoria Forbes, MD, MS, and Ritika Vankina, MD New England Clinical Oncology Society 2024 Annual Meeting, Bretton Woods, New Hampshire, October 2024.